<DOC>
	<DOCNO>NCT00363870</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy GSK Biologicals ' influenza vaccine ( Fluarixâ„¢ ) administer intramuscularly adult .</brief_summary>
	<brief_title>A Study Demonstrate Efficacy GSK Biologicals ' Influenza Vaccine Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female age 18 64 year time first vaccination . nonchildbearing female Use nonregistered product Pregnancy Hypersensitivity previous dose influenza vaccine Acute disease time enrolment/vaccination . History allergy reaction likely exacerbate component vaccine Administration influenza vaccine season 20062007 Chronic disorder pulmonary cardiovascular system , include asthma . Administration immunemodifying drug Administration immunoglobulins and/or blood product History require regular medical followup hospitalization precede year chronic metabolic disease ( include diabetes mellitus ) , renal dysfunction , hemoglobinopathy , asthma immunosuppression ( include immunosuppression cause medication human immunodeficiency virus )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>Prophylaxis Influenza vaccine</keyword>
</DOC>